A Study to Assess the Efficacy and Safety of REL-1017 as Adjunctive Treatment for Major Depressive Disorder (MDD)
Clinical trial NCT04688164 · COMPLETED
Trial details
- NCT number
- NCT04688164
- Sponsor
- Relmada Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-08
- Primary completion
- 2022-11-01
- Enrollment
- 227
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.